Search Results

You are looking at 1 - 4 of 4 items for :

Clear All
Open access

Yiqiang Huang, Lin-ang Wang, Qiubo Xie, Jian Pang, Luofu Wang, Yuting Yi, Jun Zhang, Yao Zhang, Rongrong Chen, Weihua Lan, Dianzheng Zhang and Jun Jiang

Introduction Pheochromocytomas/paragangliomas (PCC/PGLs) are tumors, arose from neural crest-derived chromaffin cells, produce and secrete catecholamines ( 1 , 2 , 3 ). PCCs are tumors of the adrenal medulla and PGLs originate from

Open access

Kranti Khadilkar, Vijaya Sarathi, Rajeev Kasaliwal, Reshma Pandit, Manjunath Goroshi, Gaurav Malhotra, Abhay Dalvi, Ganesh Bakshi, Anil Bhansali, Rajesh Rajput, Vyankatesh Shivane, Anurag Lila, Tushar Bandgar and Nalini S Shah

Introduction Malignant pheochromocytoma and paraganglioma (PCC/PGL) comprise approximately 10–20% of all pheochromocytomas and paragangliomas ( 1 ). According to the World Health Organization classification, the only accepted criterion for

Open access

Joakim Crona, Alberto Delgado Verdugo, Dan Granberg, Staffan Welin, Peter Stålberg, Per Hellman and Peyman Björklund

patients. Table 1 Clinical characteristics of sequenced patients Pre-operative characteristics Post-operative characteristics Patient no. Sex Age at diagnosis Symptoms of PCC/PGL syndrome Family history Size (mm) Bilateral/multiple lesions Diagnosis Ki67

Open access

Nicola Tufton, Lucy Shapiro, Anju Sahdev, Ajith V Kumar, Lee Martin, William M Drake, Scott A Akker and Helen L Storr

-related PCC-PGL syndromes: a clinicopathological and molecular analysis . European Journal of Endocrinology 2014 170 1 – 12 . ( https://doi.org/10.1530/EJE-13-0623 ) 24096523 10.1530/EJE-13-0623 33 Niemeijer ND Rijken JA Eijkelenkamp K van der Horst